MHY884 is an tyrosinase inhibitor that acts by suppressing UVB-induced activation of NF-κB signaling pathway through the downregulation of oxidative stress. References: Choi YJ, Uehara Y, Park JY, Kim SJ, Kim SR, Lee HW, Moon HR, Chung HY. MHY884, a newly synthesized tyrosinase inhibitor, suppresses UVB-induced activation of NF-κB signaling pathway through the downregulation of oxidative stress. Bioorg Med Chem Lett. 2014 Mar 1;24(5):1344-8. doi: 10.1016/j.bmcl.2014.01.040. Epub 2014 Jan 25. PubMed PMID: 24508132. 2: Ha YM, Uehara Y, Park D, Jeong HO, Park JY, Park YJ, Lee JY, Lee HJ, Song YM, Moon HR, Chung HY. Synthesis and preliminary in vitro biological evaluation of 5-chloro-2-(substituted phenyl)benzo[d]thiazole derivatives designed as novel antimelanogenesis agents. Appl Biochem Biotechnol. 2012 Nov;168(6):1416-33. doi: 10.1007/s12010-012-9867-5. Epub 2012 Sep 12. PubMed PMID: 22968587.

纯度：≥98%

CAS�?393371-35-1